Boomfish Wealth Group, LLC Esperion Therapeutics, Inc. Transaction History
Boomfish Wealth Group, LLC
- $173 Billion
- Q2 2025
A detailed history of Boomfish Wealth Group, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Boomfish Wealth Group, LLC holds 45,306 shares of ESPR stock, worth $114,624. This represents 0.03% of its overall portfolio holdings.
Number of Shares
45,306
Previous 34,997
29.46%
Holding current value
$114,624
Previous $50.4 Million
11.5%
% of portfolio
0.03%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding ESPR
# of Institutions
184Shares Held
106MCall Options Held
139KPut Options Held
604K-
Black Rock Inc. New York, NY14MShares$35.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$29.6 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT10.3MShares$26.2 Million0.05% of portfolio
-
Two Seas Capital LP Rye, NY9.95MShares$25.2 Million0.18% of portfolio
-
Pender Fund Capital Management Ltd. Vancouver, A16.68MShares$16.9 Million4.26% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $168M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...